Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Quest Diagnostics Elects Director

Published: Tuesday, January 14, 2014
Last Updated: Tuesday, January 14, 2014
Bookmark and Share
Quest Diagnostics announce that its Board of Directors has elected Timothy L. Main to serve as a director, effective immediately.

Tim Main currently serves as Chairman of the Board of Directors for Jabil Circuit, Inc.. Mr. Main joined Jabil in April 1987 and served in a number of operations and business development roles before being appointed Chief Executive Officer in September 2000, a role he held until 2013. As CEO, Mr. Main led Jabil's growth strategy, increasing annual revenues nearly fivefold to reach $17 billion in 2012, and expanding in Asia and other emerging markets.   

"Tim has an exceptional record of generating business growth and shareholder value in a competitive, complex global market," said Steve Rusckowski, President and CEO, Quest Diagnostics. "This experience, coupled with his deep understanding of operations and supply chain management, will enable him to share a fresh, compelling perspective on Quest as we execute our strategy to restore growth, drive operational excellence and deliver disciplined capital deployment." 

Daniel C. Stanzione, Ph.D., Chairman of the Board of Directors of Quest Diagnostics, added: "As the Chairman and former CEO of a large multinational with an operations-intensive business, Tim Main brings expertise in strategy, operations, and corporate governance that will be helpful to our company. We are pleased to welcome him to the Quest Board."

Mr. Main earned a B.S. degree from Michigan State University and Master of International Management degree from the American Graduate School of International Management (Thunderbird).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Quest Diagnostics to Acquire Laboratory Outreach Service Business
Transaction to extend laboratory partnership serving patients and physicians in Southern California while bolstering Quest's growth strategy in the region.
Wednesday, July 01, 2015
Quest Diagnostics Named "Most Admired Company"
Company earns Fortune Magazine 2015 "World's Most Admired Companies" designation by Fortune Magazine.
Tuesday, February 24, 2015
Quest Diagnostics and CDC Expand Public Health Collaboration
Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitis.
Thursday, January 29, 2015
FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test
Test kit with eight additional strains is now available directly in the United States.
Wednesday, December 10, 2014
Quest Diagnostics Adds Jeffrey M. Leiden to Board of Directors
Dr. Leiden has more than 20 years of scientific and commercial experience in the pharmaceutical and biotechnology industries.
Saturday, October 25, 2014
Quest Diagnostics Unveils New Clinical Laboratory in Marlborough, Massachusetts
Medical experts from UMass Memorial Medical Group and the University of Massachusetts to provide scientific leadership for testing onsite.
Tuesday, October 07, 2014
More People Testing Positive for Chikungunya Virus in the U.S.
Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year.
Friday, September 12, 2014
Quest Diagnostics Adds Vicky Gregg to Board of Directors
Company’s Board of Directors expand the Board to 10 members.
Friday, July 25, 2014
Quest Diagnostics Completes Acquisition of Summit Health
Summit's clients will access Quest's 2,200 patient service centers, biometric analysis.
Wednesday, April 23, 2014
UC San Francisco and Quest Diagnostics Launch Collaboration
Collaboration to advance the field of precision medicine.
Friday, January 10, 2014
Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health
Acquisition consistent with strategy to drive one to two percent in growth per year through strategically aligned fold-in acquisitions.
Friday, July 05, 2013
Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
Company has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
Wednesday, April 10, 2013
Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
In this role, Dr. Nagendran will provide medical oversight for the company's diagnostic information services.
Thursday, April 04, 2013
Federal Guidelines Recommend New HIV Testing Method
U.S. Department of Health and Human Services issues medical guidelines recommending genotypic testing to aid HIV therapy selection.
Thursday, March 28, 2013
Quest Diagnostics Reports Fourth Quarter And Full Year 2012 Financial Results; Announces 2013 Guidance
Full year record cash from operations of $1.2 billion and expanded operating margins.
Wednesday, January 23, 2013
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos